← Back to patent-cliff list
度他雄胺
Tier C — Watch / tradeDutasteride
葛兰素史克
Originator
2001
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：SRD5A
Brand：ARMADART、Avidart、Avodart、Duagen、Avolve、Yuhylyx、Zagallo、安福达
Indications (approved)：尿潴留、前列腺增生、脱发
Regional status
US
批准上市
2001-11-20
EU
无进展
2003-03-01
China
批准上市
2011-04-11
Japan
批准上市
2009-07-07
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Dutasteride?
Approved indications include: 尿潴留, 前列腺增生, 脱发.
When does the Dutasteride patent expire?
No public expiry year is available for Dutasteride yet; this page updates once verified.
How do I get a quote for Dutasteride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25